| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/15/2023 | -3.53% | Morgan Stanley | $190 → $200 | Maintains | Equal-Weight |
| 11/08/2023 | -8.35% | Morgan Stanley | $185 → $190 | Maintains | Equal-Weight |
| 09/14/2023 | -4.98% | Jefferies | $198 → $197 | Maintains | Hold |
| 08/18/2023 | -10.77% | Morgan Stanley | $171 → $185 | Maintains | Equal-Weight |
| 08/08/2023 | -17.52% | Morgan Stanley | $170 → $171 | Maintains | Equal-Weight |
| 07/10/2023 | 15.76% | Truist Securities | $220 → $240 | Maintains | Buy |
| 06/09/2023 | -2.57% | Keefe, Bruyette & Woods | $195 → $202 | Reiterates | Market Perform → Market Perform |
| 06/02/2023 | -18% | Morgan Stanley | $162 → $170 | Maintains | Equal-Weight |
| 05/11/2023 | 6.12% | Truist Securities | $210 → $220 | Maintains | Buy |
| 05/09/2023 | -21.86% | Morgan Stanley | $160 → $162 | Maintains | Equal-Weight |
| 04/13/2023 | 17.69% | Raymond James | → $244 | Initiates Coverage On | → Strong Buy |
| 03/01/2023 | -5.94% | Keefe, Bruyette & Woods | $167 → $195 | Maintains | Market Perform |
| 02/27/2023 | 1.29% | Truist Securities | $160 → $210 | Maintains | Buy |
| 02/24/2023 | -21.86% | Morgan Stanley | $150 → $162 | Maintains | Equal-Weight |
| 01/10/2023 | -27.65% | Morgan Stanley | $137 → $150 | Maintains | Equal-Weight |
| 11/17/2022 | -33.92% | Morgan Stanley | $135 → $137 | Maintains | Equal-Weight |
| 11/10/2022 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 08/17/2022 | -34.88% | Morgan Stanley | $132 → $135 | Maintains | Equal-Weight |
| 08/10/2022 | -22.82% | Truist Securities | $150 → $160 | Maintains | Buy |
| 07/06/2022 | -36.33% | Morgan Stanley | $148 → $132 | Maintains | Equal-Weight |
| 07/01/2022 | -27.65% | Truist Securities | $163 → $150 | Maintains | Buy |
| 05/19/2022 | -28.61% | Morgan Stanley | → $148 | Downgrades | Overweight → Equal-Weight |
| 05/06/2022 | -26.2% | Morgan Stanley | $157 → $153 | Maintains | Overweight |
| 04/08/2022 | -24.27% | Morgan Stanley | $159 → $157 | Maintains | Overweight |
| 03/01/2022 | -9.8% | Credit Suisse | $199 → $187 | Maintains | Outperform |
| 02/22/2022 | -23.31% | Morgan Stanley | $175 → $159 | Maintains | Overweight |
| 02/15/2022 | -15.59% | Morgan Stanley | $180 → $175 | Maintains | Overweight |
| 01/26/2022 | -22.82% | Jefferies | → $160 | Initiates Coverage On | → Hold |
| 01/21/2022 | -21.38% | Wolfe Research | → $163 | Initiates Coverage On | → Peer Perform |
| 01/07/2022 | -13.18% | Morgan Stanley | $175 → $180 | Maintains | Overweight |
| 10/14/2021 | -15.59% | Morgan Stanley | $170 → $175 | Maintains | Overweight |
| 06/21/2021 | -30.54% | Citigroup | $140 → $144 | Maintains | Sell |
| 05/07/2021 | -18% | Morgan Stanley | $165 → $170 | Maintains | Overweight |
| 04/20/2021 | -9.32% | Truist Securities | $165 → $188 | Maintains | Buy |
| 04/01/2021 | -20.41% | Morgan Stanley | $160 → $165 | Maintains | Overweight |
| 02/11/2021 | -22.82% | Morgan Stanley | $155 → $160 | Maintains | Overweight |
| 01/25/2021 | -20.41% | Truist Securities | $155 → $165 | Maintains | Buy |
| 01/15/2021 | -25.24% | Morgan Stanley | $142 → $155 | Maintains | Overweight |
| 10/06/2020 | -31.51% | Morgan Stanley | $149 → $142 | Maintains | Overweight |
| 09/15/2020 | -28.13% | Morgan Stanley | → $149 | Initiates Coverage On | → Overweight |
| 08/10/2020 | -25.24% | Truist Securities | $145 → $155 | Maintains | Buy |
| 07/17/2020 | -30.06% | SunTrust Robinson Humphrey | $135 → $145 | Maintains | Buy |
| 06/08/2020 | -23.31% | Credit Suisse | $128 → $159 | Maintains | Outperform |
| 05/01/2020 | -34.88% | SunTrust Robinson Humphrey | $130 → $135 | Maintains | Buy |
| 04/20/2020 | -37.3% | SunTrust Robinson Humphrey | $100 → $130 | Maintains | Buy |
| 03/23/2020 | — | SunTrust Robinson Humphrey | Upgrades | Hold → Buy | |
| 02/13/2020 | — | William Blair | Upgrades | Market Perform → Outperform | |
| 03/18/2019 | -28.61% | Credit Suisse | $135 → $148 | Maintains | Outperform |
| 01/18/2019 | -34.88% | Credit Suisse | → $135 | Initiates Coverage On | → Outperform |
What is the target price for Primerica (PRI)?
The latest price target for Primerica (NYSE: PRI) was reported by Morgan Stanley on November 15, 2023. The analyst firm set a price target for $200.00 expecting PRI to fall to within 12 months (a possible -3.53% downside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Primerica (PRI)?
The latest analyst rating for Primerica (NYSE: PRI) was provided by Morgan Stanley, and Primerica maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Primerica (PRI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Primerica, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Primerica was filed on November 15, 2023 so you should expect the next rating to be made available sometime around November 15, 2024.
Is the Analyst Rating Primerica (PRI) correct?
While ratings are subjective and will change, the latest Primerica (PRI) rating was a maintained with a price target of $190.00 to $200.00. The current price Primerica (PRI) is trading at is $207.32, which is out of the analyst's predicted range.